MRSE

CAIRE Reporting, LLC Launches the First Comprehensive Adverse Incident Reporting Web Portal for Magnetic Resonance Imaging

Retrieved on: 
Thursday, November 16, 2023
Magnetic resonance imaging, MRSE, Acquisition, Safety, Alexander Gilkes, Magnetic resonance, Patient, Data analysis, Aggregation, American College, MRI, ACR, Accident, Adrian Dixon, Medical imaging, Portal

CAMDEN, Del., Nov. 16, 2023 /PRNewswire/ -- CAIRE Reporting, LLC launches the first web-based portal for adverse incident reporting for Magnetic Resonance Imaging (MRI) scanners throughout the world.

Key Points: 
  • CAMDEN, Del., Nov. 16, 2023 /PRNewswire/ -- CAIRE Reporting, LLC launches the first web-based portal for adverse incident reporting for Magnetic Resonance Imaging (MRI) scanners throughout the world.
  • Founded in 2023, CAIRE Reporting, LLC was established with the directives of enhancing accident information collection, incident data analysis and corrective action recommendations.
  • Comprehensive Adverse Incident Reporting and Evaluation (CAIRE) is uses a proprietary data acquisition methodology that is highly curated and pertinent to the subject workspace.
  • CAIRE Reporting, LLC, and The CAIRE MRI Portal represent intellectual property rights of CAIRE Reporting, LLC, in the United States and/or other countries.

Genesis MedTech introduces China's first domestic brand of NPMA-approved antibacterial sutures

Retrieved on: 
Tuesday, September 12, 2023
Triclosan, Suture, Staphylococcus, Staphylococcus epidermidis, Infection, MRSA, Gram-negative bacteria, Hospital-acquired infection, Staphylococcus aureus, CDC, MRSE, Patient, Risk, Korea Disease Control and Prevention Agency, Perioperative, National Medical Products Administration, Growth, Methicillin-resistant Staphylococcus aureus, WHO, JAMA Surgery, Lancet, NMPA, Genesis, Dis, World Health Organization, Pharmaceutical industry, Vaccine

The newly developed antibacterial sutures are coated with triclosan, a broad-spectrum antimicrobial agent with activity against gram-positive and gram-negative bacteria.

Key Points: 
  • The newly developed antibacterial sutures are coated with triclosan, a broad-spectrum antimicrobial agent with activity against gram-positive and gram-negative bacteria.
  • Alongside the highly anticipated absorbable antibacterial sutures, Genesis MedTech continues to expand its suture product lines with comprehensive offerings.
  • Furthermore, its barbed absorbable sutures with black needle, non-absorbable surgical polypropylene sutures, and controlled-release needle sutures have been widely used in thousands of hospitals nationwide.
  • Warren Wang, Chairman and CEO of Genesis MedTech Group, expressed his excitement stating, "We are thrilled to achieve this significant milestone as the first domestic brand in China to develop antibacterial sutures.

Independent Lab Tests Prove CASPR Technology Beats Competitors

Retrieved on: 
Tuesday, March 29, 2022
Virus, MRSE, HVAC, Bacteria, ISS National Lab, ARE, Laboratory, Atmosphere, Technology, GLOBE, CASPR, Ion, FDA, MRSA, Biophysical environment, Vaccine, Engineering

DALLAS, March 29, 2022 (GLOBE NEWSWIRE) -- Environmental health technology company CASPR Technologies has beat two competing technologies in independent laboratory testing.

Key Points: 
  • DALLAS, March 29, 2022 (GLOBE NEWSWIRE) -- Environmental health technology company CASPR Technologies has beat two competing technologies in independent laboratory testing.
  • Kansas-based Aerosol Research and Engineering (ARE) Laboratories tested CASPR technology against air and surface purification units from two other companies and found that CASPR Tech's models topped out at a 99% reduction in pathogens compared to its competitors' 45% reduction.
  • The two CASPR Tech models used were CASPR PRO 2500 and CASPR MEDIK 14".
  • The value proposition of the NCC technology continues to prove that it is the best path forward when talking about reducing pathogens on surfaces and in the air," said CASPR Technologies co-founder Dr. Christophe Suchy, who invented the technology.